Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 65862-497

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 65862-497). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (600 mg/200 mg/300 mg (30 Tablet Bottle))

Label for Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, film-coated, with strengths of 600 mg, 200 mg, and 300 mg respectively, supplied in a package of 30 tablets. The label includes dosage storage instructions, manufacturer information (Aurobindo Pharma USA, Inc.), and pharmacy warnings. The product is distributed by Aurobindo Pharma USA and made in India, with a designated coding area for batch and expiry information.*

FDA Label Image

Efavirenz Chemical Structure (Efemtf Str1)

Chemical structure of efavirenz, emtricitabine, and tenofovir disoproxil fumarate. The diagram shows a molecular structure with rings, functional groups, and bonds typical of pharmaceutical compounds.*

FDA Label Image

Emitricitabine Chemical Structure (Efemtf Str2)

Chemical structure of efavirenz, one of the active ingredients in the combination drug containing efavirenz, emtricitabine, and tenofovir disoproxil fumarate. The structure shows the characteristic fused rings, fluorine atom, and functional groups associated with efavirenz.*

FDA Label Image

Tenofovir Chemical Structure (Efemtf Str3)

Chemical structure of the active ingredient in the drug product labeled for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE. The diagram shows molecular bonds and atom arrangements characteristic of this combination drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.